Hot pick: Low PE high ROC stock under Rs 100 bags Rs 38 crore order; Do you have it in your portfolio?

Hot pick: Low PE high ROC stock under Rs 100 bags Rs 38 crore order; Do you have it in your portfolio?

Vaishnavi Chauhan
/ Categories: Trending, Mindshare

Anant Agarwal, holding a 4.09 per cent stake in the company.

Thursday deals concluded on a downtrend, with both the Sensex and Nifty closing lower by 0.47 per cent and 0.46 per cent respectively.

Today, Quality Biz Chem India Private Limited, a distinguished private limited company has awarded a significant Purchase Order upon Aristo Bio-Tech and Lifescience Limited.

Since its establishment in 2005, Aristo Bio-Tech and Lifescience Limited has etched its mark as a prominent player in the agrochemical landscape. Specializing in the manufacturing, formulation, supply, packaging, and job work services of a diverse range of pesticides, the company stands at the forefront of agricultural innovation.

Purchase Order, valued at Rs 38,08,000 (38 crore) entails the supply of an array of Agrochemicals on a Freight-Paid Basis.

The significance of this order lies not only in its monetary value but also in its potential to expand the company's customer base, contributing positively to its overall profitability.

Anant Aggarwal, holding a 4.09 per cent stake in the company, adds another layer to Aristo's narrative. As an Angel Investor hailing from Delhi, Anant Agarwal has showcased his investment in sectors like Apps and Fin-Tech, leaving his footprint on startups such as Zenpay Solutions and Galaxycard.

While Aristo Bio-Tech and Lifescience Limited is yet to unveil its Q1FY24 results.

Promoters' confidence shines through in the figures, with March 2023 showcasing their strong hold on 73.37 per cent of shares, while the public holds 26.62 per cent. Notably, the promoters' holding remains unencumbered, symbolizing their steadfast commitment to the company's growth and success.

Furthermore, With a low Price-to-Earnings (P/E) ratio of 13.6, the stock reflects its value compared to earnings. The solid Return on Equity (ROE) of 24 per cent highlights the company's effective use of resources and its capability to provide favorable returns to shareholders.

Today, the shares of Aristo Bio-Tech and Lifescience Limited plunged 1.53 per cent.  The company's current market capitalisation is Rs 48.3 crore.

Due to its recent listing, there is limited available data for the company at this point.

DSIJ offers a service 'Tiny Treasure' with recommendations for Small-Cap stocks based on research and analysis to help subscribers make informed investment decisions. If this interests you, then do download the service details pdf here

Keep close eye on this trending stock.

Disclaimer: The article is for informational purposes only and not investment advice.

Previous Article 162 per cent jump in net profit: This small-cap stock surged by more than 34 per cent over the past 5 days!
Next Article Rs 20,000 crore order book: This Vijay Kedia's multibagger stock reports more than 280 per cent jump in net profit; Do you own it?
Rate this article:
3.7

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR